Literature DB >> 2713974

Sources of variability in normal body surface potential maps.

G Kozmann1, R L Lux, L S Green.   

Abstract

Within-group variability of body surface potential maps was assessed on data from 685 carefully validated normal subjects (348 men and 337 women). Sources of within-group variability were evaluated by subgrouping maps by patient sex, age, height, and weight. Contribution of reproducibility error to total variance was assessed in a separate group of 52 normal subjects in whom multiple maps were recorded. Total variance was significantly lower in women than in men. Total variance tended to decrease with age, and the greatest decrease occurred in men during the 3rd decade. The ratio of total variance to mean signal energy showed a slow decrease with age for each group. Results suggest that the dominant source of within-group variability arises from variability of cardiac electric sources while the influence of volume conductor variability is significantly less. Variability due to measurement reproducibility was approximately half of the total variance.

Entities:  

Mesh:

Year:  1989        PMID: 2713974     DOI: 10.1161/01.cir.79.5.1077

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  3 in total

1.  Aspects of left ventricular morphology outperform left ventricular mass for prediction of QRS duration.

Authors:  Nina Hakacova; Katarina Steding; Henrik Engblom; Jane Sjögren; Charles Maynard; Olle Pahlm
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-04       Impact factor: 1.468

2.  Modeling vectorcardiograms based on left ventricle papillary muscle position.

Authors:  Zak Loring; Charles W Olson; Charles Maynard; Nina Hakacova
Journal:  J Electrocardiol       Date:  2011 Sep-Oct       Impact factor: 1.438

Review 3.  Electrocardiographic body surface mapping: potential tool for the detection of transient myocardial ischemia in the 21st century?

Authors:  Monique R Robinson; Nicholas Curzen
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-04       Impact factor: 1.468

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.